Medical Devices; number of pages: 101; published: Sep-24

    • Europe Hearing Aids Market Forecast to 2030

    • Europe Hearing Aids Market Forecast to 2030 - Regional Analysis - by Type (Prescription Hearing Aids and OTC Hearing Aids), Product Type (Hearing Aid Devices and Hearing Implants), Technology (Conventional Hearing Aids and Digital Hearing Aids), Type Of Hearing Loss (Sensorineural Hearing Loss and Conductive Hearing Loss), Patient Type (Adults and Pediatric), and Distribution Channel (Pharmacies, Retail Stores, and Online)
    • $2,485 – $3,885

    • Europe Surgical Navigation Systems Market Forecast to 2030

    • Europe Surgical Navigation Systems Market Forecast to 2030 - Regional Analysis - by Type (Optical Navigation System, Electromagnetic Navigation System, Hybrid Navigation System, Fluroscopy Navigation System, CT-Based Navigation System, and Others), Application (Orthopedic, ENT, Neurology, Dental, and Others), and End User [Hospitals and Ambulatory Surgical Centers (ASCs)]
    • $2,485 – $3,885

    • Middle East & Africa Vital Signs Monitoring Devices Market Forecast to 2030

    • Middle East & Africa Vital Signs Monitoring Devices Market Forecast to 2030 - Regional Analysis - By Product (Pulse Oximeters, Blood Pressure Monitors, Temperature Monitoring Devices, and Glucose Monitoring Devices) and End User (Hospitals & Clinics, Ambulatory Care Centers, Home Healthcare, and Others)
    • $2,485 – $3,885

    • North America Vital Signs Monitoring Devices Market Forecast to 2030

    • North America Vital Signs Monitoring Devices Market Forecast to 2030 - Regional Analysis - By Product (Pulse Oximeters, Blood Pressure Monitors, Temperature Monitoring Devices, and Glucose Monitoring Devices) and End User (Hospitals & Clinics, Ambulatory Care Centers, Home Healthcare, and Others)
    • $2,485 – $3,885

    • South & Central America Molecular Diagnostics for Infectious Disease Market Forecast to 2030

    • South & Central America Molecular Diagnostics for Infectious Disease Market Forecast to 2030 - Regional Analysis - by Type (Point-of-Care Testing and Laboratory Testing), End User [Point-of-Care Testing (Human Testing and Vet Testing) and Laboratory Testing (Human Testing and Vet Testing)], Application [Point-of-Care Testing (Detection of Single Pathogen, Detection of Two or More Pathogens, Evaluation of Emerging Novel Infections, Surveillance and Early Detection of Biothreat Agents and Diseases-Related Biomarker, and Antimicrobial Resistance Profiling) and Laboratory Testing (Patient stratification, Drug Regimen Selection, Toxicity Avoidance, Therapeutic Monitoring, and Detection of Predisposition to Disease)], Disease Type [Point-of-Care Testing (Sepsis, Prosthetic Joint Infection (PJI), Endocarditis, STDs, Mononucleosis, Group A Streptococcus (GAS), and Others) and Laboratory Testing (Sepsis, Prosthetic Joint Infection (PJI), Endocarditis, STDs, Chlamydia, Gastrointestinal Infection, Tuberculosis, H1N1 Virus, and Others)], Infection Type [Point-of-Care Testing (Bacteria, Viral, Fungi, and Others) and Laboratory Testing (Bacteria, Viral, Fungi, and Others)]
    • $2,485 – $3,885